Skip to main content
SpringerLink
Log in

Negative-type electroretinogram from cisplatin toxicity

  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

A 68-year-old woman with ovarian cancer suffered a loss of visual acuity and color perception after inadvertent overdosage with the antineoplastic agent cisplatin. Her acuity returned to normal but a tritan color defect persisted more than a year later. Her electroretinogram was stable between 7 weeks and 15 months after cisplatin administration, with a negative-type scotopic response, but also reduced cone b waves and a loss of some scotopic oscillatory potentials. With light stimuli between 10 and 100 ms in duration, the photopic on-responses were markedly reduced while the off-responses were normal or close to it. This case suggests that cisplatin may selectively injure on-pathways in the retina and indicates the need to expand the list of disorders that may cause a negative-type electroretinogram.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CSNB:

congenital stationary night blindness

References

  1. Schubert G, Bornschein H. Beitrag zur Analyse des menschlichen Elektroretinogramms. Ophthalmologica 1952; 123: 396–413.

    PubMed  Google Scholar 

  2. Carr RE. Congenital stationary nightblindness. Trans Am Ophthalmol Soc 1974; 72: 448–87.

    PubMed  Google Scholar 

  3. Miyake Y, Yagasaki K, Horiguchi M, Kawase Y, Kanda T. Congenital stationary night blindness with negative electroretinogram. Arch Ophthalmol 1986; 104: 1013–20.

    PubMed  Google Scholar 

  4. Ripps H, Carr RE, Siegel IM, Greenstein VC. Functional abnormalities in vincristineinduced night blindness. Invest Ophthalmol Vis Sci 1984; 25: 787–94.

    PubMed  Google Scholar 

  5. Berson EL, Lessell S. Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol 1988; 106: 307–11.

    PubMed  Google Scholar 

  6. Alexander KR, Fishman GA, Peachey NS, Marchese AL, Tso MOM. ‘On’ response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci 1992; 33: 477–83.

    PubMed  Google Scholar 

  7. Miyake Y, Yagasaki K, Horiguchi M, Kawase Y. On- and off-responses in photopic electroretinogram in complete and incomplete types of congenital stationary night blindness. Jpn J Ophthalmol 1987; 31: 81–7.

    PubMed  Google Scholar 

  8. Houchin KW, Purple RL, Wirtschafter JD. X-linked congenital stationary night blindness and depolarizing bipolar system dysfunction. Invest Ophthalmol Vis Sci 1991; 32(suppl.): 1229.

    Google Scholar 

  9. Young RSL. Low-frequency component of the photopic ERG in patients with X-linked congenital stationary night blindness. Clin Vision Sci 1991; 6: 309–15.

    Google Scholar 

  10. Marmor MF, Arden GB, Nilsson SE, Zrenner E. Standard for clinical electroretinography. Arch Ophthalmol 1989; 107: 816–9. Reprinted with permission in Doc Ophthalmol 1989; 73(4): 303–11.

    PubMed  Google Scholar 

  11. Daw NW, Jensen RJ, Brunken WJ. Rod pathways in mammalian retinae. Trends Neurosci 1990; 13: 110–5.

    PubMed  Google Scholar 

  12. Ripps H. Night blindness revisited. From man to molecules. Invest Ophthalmol Vis Sci 1982; 23: 588–609.

    PubMed  Google Scholar 

  13. Krill AE, Martin D. Photopic abnormalities in congenital stationary nightblindness. Invest Ophthalmol 1971; 10: 625–36.

    PubMed  Google Scholar 

  14. Ripps H, Mehaffey L III, Siegel IM, Niemeyer G. Vincristine-induced changes in the retina of the isolated arterially-perfused cat eye. Exp Eye Res 1989; 48: 771–90.

    PubMed  Google Scholar 

  15. Lachapelle P, Little JM, Polomeno RC. The photopic electroretinogram in congenital stationary night blindness with myopia. Invest Ophthalmol Vis Sci 1983; 24: 442–50.

    PubMed  Google Scholar 

  16. Wilding G, Caruso R, Lawrence TS, Ostchega Y, Ballintine EJ, Young RC, Ozols RF. Retinal toxicity after high-dose cisplatin therapy. J Clin Oncol 1985; 3: 1683–9.

    PubMed  Google Scholar 

  17. Miller DF, Bay JW, Lederman RJ, Purvis JD, Rogers LR, Tomsak RL. Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas. Ophthalmology 1985; 92: 402–6.

    PubMed  Google Scholar 

  18. Kupersmith MJ, Frohman LP, Choi IS, Foo SH, Hiesinger E, Berenstein A, Wise A, Carr RE, Ransohoff J. Visual system toxicity following intra-arterial chemotherapy. Neurology 1988; 38: 284–9.

    PubMed  Google Scholar 

  19. Kupersmith MJ, Seiple WH, Holopigian K, Noble K, Hiesiger E, Warren F. Maculopathy caused by intra-arterially administered cisplatin and intravenously administered carmustine. Am J Ophthalmol 1992; 113: 435–8.

    PubMed  Google Scholar 

  20. Greenberg D, Fishman G, Tripathi R, Tripathi B, Peyman GA. The effects of intravitreal cisplatinum. Invest Ophthalmol Vis Sci 1985; 26(suppl): 60.

    Google Scholar 

  21. Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF. Blindness is caused by photoreceptor degeneration as a remote effect on cancer. Am J Ophthalmol 1976; 81: 606–13.

    PubMed  Google Scholar 

  22. Keltner JL, Roth AM, Chang RS. Photoreceptor degeneration. Arch Ophthalmol 1983; 101: 564–9.

    PubMed  Google Scholar 

  23. Perry MC, ed. The chemotheraphy source book. Baltimore: Williams & Wilkins, 1992.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Stanford University School of Medicine, 94305-5308, Stanford, California, USA

    Michael F. Marmor

Authors
  1. Michael F. Marmor
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marmor, M.F. Negative-type electroretinogram from cisplatin toxicity. Doc Ophthalmol 84, 237–246 (1993). https://doi.org/10.1007/BF01203656

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01203656

Key words

Search

Navigation